<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR6">
 <label>6.</label>
 <mixed-citation publication-type="other">European Medicines Agency. Guideline on good pharmacovigilance practices (GVP) Module VI â€“ Collection, management and submission of reports of suspected adverse reactions to medicinal products (Rev.2). EMA. 2017. 
  <ext-link ext-link-type="uri" xlink:href="https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/guideline-good-pharmacovigilance-practices-gvp-module-vi-collection-management-submission-reports_en.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/guideline-good-pharmacovigilance-practices-gvp-module-vi-collection-management-submission-reports_en.pdf</ext-link>. Accessed 24 Jan 2020.
 </mixed-citation>
</ref>
